Four Years in a Row! Dian Diagnostics and Roche Diagnostics Signed a Contract at the China International Import Expo

On November 5, at the 4th China International Import Expo - Zhejiang Province International Medical Materials Procurement Signing Conference, Dian Diagnostics and Roche Diagnostics (Shanghai) Co., Ltd. signed the "Letter of Intent for Procurement of Imported Medical Devices". This is the fourth consecutive year that Dian Diagnostics has reached relevant procurement intentions with Roche Diagnostics at the China International Import Expo, showing a good momentum of cooperation.

Shen Lijun, senior vice president of Dian Diagnostics, and Wang Shaodong, sales area manager of Roche Diagnostics (Shanghai) Co., Ltd., signed the contract on behalf of both parties. Gong Yuanchang, first-level inspector of Zhejiang Provincial Medical Security Bureau, Su Changcong, first-level inspector of Zhejiang Provincial Health and Health Commission, Hu Weikang, first-level inspector of Zhejiang Provincial Department of Commerce, Lu Jianbo, director of the Consumer Products Division (Biomedical Industry Division) of the Provincial Department of Economy and Information Technology, etc. People attended the signing ceremony and witnessed the signing activities.

In an interview with reporters at the scene, Shen Lijun said that this year, Dian Diagnostics' intended purchase amount will reach 200 million yuan, and the purchases are Roche Diagnostics' in vitro diagnostics, biochemical immunity and instrument reagents. "The fourth CIIE has continued to accelerate the introduction of excellent international products, greatly broadening and optimizing our procurement channels, demonstrating that Zhejiang's medical supplies are constantly advancing in line with international advanced technology and capital, and at the same time improving the service of Dian Diagnostics. The brand's popularity in the domestic and international markets." Shen Lijun said.

This year's Zhejiang Province International Medical Supplies Procurement Signing Conference was jointly organized by Zhejiang Provincial Medical Security Bureau, Zhejiang Provincial Health Commission, Zhejiang Provincial Department of Economy and Information Technology and Zhejiang Provincial Department of Commerce. The signing activities are divided into three parts: international import of medicines, international import of medical consumables, and social medical import enterprises. The total purchase intention is about 10.22 billion yuan, ranking the forefront of all trading groups in the province.

In addition, Dian Diagnostics, as the only designated service provider for nucleic acid testing at the conference, provides testing services for guests, staff and other participants from all over the country to ensure the safety of epidemic prevention at the signing conference. According to the relevant epidemic prevention and control arrangements, Dian Diagnostics set up on-site sampling points outside the venue on the 4th and 5th, and equipped all consumables and protective materials. The group's distribution team dispatched special personnel and vehicles to deliver the samples to the laboratory in a timely manner and quickly issued a report.

As a pioneer in the domestic third-party diagnostic industry, Dian Diagnostics is committed to providing customers with "overall solutions for medical diagnostic services". At present, it has deployed 40 chain laboratories across the country, providing services to more than 20,000 medical institutions and 300 million people across the country. Services; actively reach strategic cooperation with international leading medical companies, professional colleges and scientific research institutions, and introduce precision diagnosis and treatment technologies such as biological mass spectrometry, metabolomics, and gene sequencing into China; in the fight against the new crown epidemic, Dian Diagnostics takes professional responsibility , in the form of joint operations between central laboratories and "Dian Reddy" square cabin laboratories in various places, to help the new crown nucleic acid screening in various places.

In the future, Dian Diagnostics will continue to uphold the mission of "Let the Chinese people share health equally", to make international advanced medical services and medical equipment benefit the domestic people, vigorously promote the upgrading of the health industry to high quality and diversification, and comprehensively promote the construction of a healthy China.